Filter
7289
Filtered Results: 7289
Text search:
World
Health
Organization
WHO
(Africa)
Featured
Recommendations
647
New Publications
1701
Language
Document type
No document type
4008
Studies & Reports
1445
Guidelines
794
Manuals
319
Strategic & Response Plan
266
Fact sheets
173
Training Material
109
Situation Updates
83
Resource Platforms
26
Infographics
24
Online Courses
24
Brochures
12
Videos
4
App
2
Countries / Regions
Global
336
Kenya
244
South Africa
239
Sierra Leone
202
Africa
193
Nigeria
185
Liberia
184
Ethiopia
178
Uganda
162
Zambia
124
Malawi
124
Rwanda
109
Ghana
105
Middle East and North Africa
104
India
103
Congo, Democratic Republic of
102
Tanzania
102
West and Central Africa
93
Latin America and the Carribbean
90
Mozambique
85
Syria
81
East and Southern Africa
77
South Sudan
76
Western and Central Europe
72
Guinea
69
Lesotho
65
Senegal
63
Zimbabwe
63
Namibia
63
Yemen
60
Nepal
59
Burkina Faso
50
Bangladesh
44
Russia
41
Cameroon
38
Ukraine
37
Botswana
37
Central African Republic
33
Myanmar / Burma
32
Asia
32
Mali
30
Sudan
30
Benin
30
Brazil
30
South–East Asia Region
30
Angola
28
Eswatini/ Swaziland
27
Colombia
27
Haiti
26
Indonesia
26
Eastern Europe
26
Somalia
23
Madagascar
23
Cambodia
22
Côte d’Ivoire / Ivory Coast
21
China
21
Venezuela
20
Germany
19
Philippines
17
Pakistan
17
Guinea-Bissau
16
Afghanistan
16
Chad
14
Thailand
13
Eastern Europe and Central Asia
13
Vietnam
12
Niger
11
Southern Africa
11
Lebanon
10
Iraq
9
Jordan
9
Saudi Arabia
8
Togo
8
Burundi
8
Libya
8
Chile
8
Western Pacific Region
8
Egypt
7
Peru
7
Ecuador
7
Mexico
7
Paraguay
7
North America
7
Gambia
6
Papua New Guinea
6
Iran
6
Tunisia
6
Morocco
5
Sri Lanka
5
Jamaica
5
Japan
5
Portugal
5
USA
4
Mauritania
4
Greece
4
Palestine
4
Albania
4
Laos
4
Georgia
4
Turkey
3
Malaysia
3
Argentina
3
North Macedonia
3
Serbia
3
Djibouti
3
Tajikistan
3
Qatar
3
Moldova
3
Kyrgyzstan
3
Kazakhstan
3
Gabon
3
France
3
Mauritius
3
Spain
3
Israel
3
Bosnia and Herzegovina
3
Honduras
2
El Salvador
2
Bolivia
2
Italy
2
Armenia
2
Congo-Brazzaville
2
Canada
2
Turkmenistan
2
Belarus
2
Vanuatu
1
Dominican Republic
1
Hungary
1
Croatia
1
Cuba
1
Guatemala
1
Cape Verde
1
Nicaragua
1
Solomon Islands
1
Poland
1
North Korea
1
Mongolia
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Romania
1
Uruguay
1
Denmark
1
Belgium
1
United Kingdom
1
Norway
1
Algeria
1
Morocco
1
Azerbaijan
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
2500
Clinical Guidelines
614
Public Health
416
Women & Child Health
402
Key Resources
301
Capacity Building
135
Pharmacy & Technologies
79
Annual Report MEDBOX
2
Toolboxes
HIV
700
COVID-19
648
Mental Health
482
TB
411
Ebola
341
Disability
302
Planetary Health
291
Rapid Response
248
NTDs
230
AMR
179
Caregiver
173
Global Health Education
170
Conflict
146
NCDs
136
Refugee
129
Pharmacy
116
Health Financing Toolbox
100
Natural Hazards
64
Zika
54
Polio
47
Cholera
44
Social Ethics
27
Specific Hazards
23
Typhoon
3
South Sudan
2
Health Financing
1
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Nigeria reported its first case of COVID-19 at the end of February 2020 and subsequently experienced
four waves, with peaks in June 2020 and January, August and December 2021. The COVID-19 pandemic
severely impacted the economy of Nigeria and caused disruption of health services nationwide. During...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
Groupe indépendant d’experts de la redevabilité de l’initiative Chaque femme, chaque enfant. (2020). Dans la tourmente de la pandémie de COVID-19: la santé de la femme, de l’enfant et de l’adolescent dans le contexte de la couverture sanitaire universelle et des objectifs de dével...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ...
